These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12060574)

  • 1. Treatment of established asthma in a murine model using CpG oligodeoxynucleotides.
    Kline JN; Kitagaki K; Businga TR; Jain VV
    Am J Physiol Lung Cell Mol Physiol; 2002 Jul; 283(1):L170-9. PubMed ID: 12060574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intranasal administration of CpG oligodeoxynucleotides reduces lower airway inflammation in a murine model of combined allergic rhinitis and asthma syndrome.
    Li HT; Zhang TT; Chen ZG; Ye J; Liu H; Zou XL; Wang YH; Yang HL
    Int Immunopharmacol; 2015 Sep; 28(1):390-8. PubMed ID: 26163938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CpG oligodeoxynucleotides can reverse Th2-associated allergic airway responses and alter the B7.1/B7.2 expression in a murine model of asthma.
    Serebrisky D; Teper AA; Huang CK; Lee SY; Zhang TF; Schofield BH; Kattan M; Sampson HA; Li XM
    J Immunol; 2000 Nov; 165(10):5906-12. PubMed ID: 11067952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure.
    Jain VV; Businga TR; Kitagaki K; George CL; O'Shaughnessy PT; Kline JN
    Am J Physiol Lung Cell Mol Physiol; 2003 Nov; 285(5):L1137-46. PubMed ID: 12857672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccinations with T-helper type 1 directing adjuvants have different suppressive effects on the development of allergen-induced T-helper type 2 responses.
    Trujillo-Vargas CM; Mayer KD; Bickert T; Palmetshofer A; Grunewald S; Ramirez-Pineda JR; Polte T; Hansen G; Wohlleben G; Erb KJ
    Clin Exp Allergy; 2005 Aug; 35(8):1003-13. PubMed ID: 16120081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IFN-γ-mediated efficacy of allergen-free immunotherapy using mycobacterial antigens and CpG-ODN.
    Fonseca DM; Paula MO; Wowk PF; Campos LW; Gembre AF; Turato WM; Ramos SG; Dias-Baruffi M; Barboza R; Gomes E; Horn C; Marchal G; Arruda LK; Russo M; Bonato VL
    Immunol Cell Biol; 2011 Oct; 89(7):777-85. PubMed ID: 21403663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of murine allergic rhinosinusitis by CpG oligodeoxynucleotides.
    Hussain I; Jain VV; Kitagaki K; Businga TR; O'Shaughnessy P; Kline JN
    Laryngoscope; 2002 Oct; 112(10):1819-26. PubMed ID: 12368622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ribavirin or CpG DNA sequence-modulated dendritic cells decrease the IgE level and airway inflammation.
    Chiang DJ; Ye YL; Chen WL; Lee YL; Hsu NY; Chiang BL
    Am J Respir Crit Care Med; 2003 Sep; 168(5):575-80. PubMed ID: 12941656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma.
    Kline JN; Waldschmidt TJ; Businga TR; Lemish JE; Weinstock JV; Thorne PS; Krieg AM
    J Immunol; 1998 Mar; 160(6):2555-9. PubMed ID: 9510150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel mannoside-glycocluster adjuvant: Compared in vitro to CpG ODN and MPL and tested in vivo in mouse asthma model.
    Mäkinen K; Mukherjee C; Leino M; Panchadhayee R; Lehto M; Wolff H; Alenius H; Leino R; Savolainen J
    Allergol Immunopathol (Madr); 2016; 44(1):9-17. PubMed ID: 26395525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of murine airway eosinophilia and Th2 cells by antigen-conjugated CpG oligodeoxynucleotides as a novel antigen-specific immunomodulator.
    Shirota H; Sano K; Kikuchi T; Tamura G; Shirato K
    J Immunol; 2000 Jun; 164(11):5575-82. PubMed ID: 10820231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of CpG oligonucleotides in treatment of asthma and allergic disease.
    Fonseca DE; Kline JN
    Adv Drug Deliv Rev; 2009 Mar; 61(3):256-62. PubMed ID: 19167442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulatory effects of CpG oligodeoxynucleotides on established th2 responses.
    Kitagaki K; Jain VV; Businga TR; Hussain I; Kline JN
    Clin Diagn Lab Immunol; 2002 Nov; 9(6):1260-9. PubMed ID: 12414759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of CpG-ODNs suppresses antigen-induced asthma in mice.
    Kitagaki K; Businga TR; Kline JN
    Clin Exp Immunol; 2006 Feb; 143(2):249-59. PubMed ID: 16412048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long term prevention of allergic lung inflammation in a mouse model of asthma by CpG oligodeoxynucleotides.
    Sur S; Wild JS; Choudhury BK; Sur N; Alam R; Klinman DM
    J Immunol; 1999 May; 162(10):6284-93. PubMed ID: 10229876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice vaccinated with allergen-pulsed myeloid dendritic cells are not protected from developing allergen-induced Th2 responses.
    Trujillo-Vargas CM; Ramirez-Pineda JR; Palmetshofer A; Grunewald S; Moll H; Berberich C; Erb KJ
    Int Arch Allergy Immunol; 2005 Jul; 137(3):219-28. PubMed ID: 15956790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CpG ODN mediated prevention from ovalbumin-induced anaphylaxis in mouse through B cell pathway.
    Xu W; Tamura T; Takatsu K
    Int Immunopharmacol; 2008 Feb; 8(2):351-61. PubMed ID: 18182251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel Ag-specific immunotherapy using CpG oligodeoxynucleotides in a new, unique mouse cutaneous eosinophilic inflammation model.
    Kootiratrakarn T; Fujimura T; Sano K; Okuyama R; Aiba S; Tagami H; Terui T
    Eur J Immunol; 2005 Nov; 35(11):3277-86. PubMed ID: 16245360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CpG-ODN inhibits airway inflammation at effector phase through down-regulation of antigen-specific Th2-cell migration into lung.
    Ashino S; Wakita D; Zhang Y; Chamoto K; Kitamura H; Nishimura T
    Int Immunol; 2008 Feb; 20(2):259-66. PubMed ID: 18156622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of Th2 responses by peptide analogues in a murine model of allergic asthma: amelioration or deterioration of the disease process depends on the Th1 or Th2 skewing characteristics of the therapeutic peptide.
    Janssen EM; van Oosterhout AJ; van Rensen AJ; van Eden W; Nijkamp FP; Wauben MH
    J Immunol; 2000 Jan; 164(2):580-8. PubMed ID: 10623798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.